Thomas A. Paul
Impact in
- Oncology top 5%
- Lymphatic System and Diseases
- Cutaneous Melanoma Detection and Management
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Angiogenesis and VEGF in Cancer
- Chromatin Remodeling and Cancer
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 3
- CRISPR and Genetic Engineering 3
- Oncology 7
- Co-authors
- Claus Garbe (2 shared papers)Michael J. Detmar (1 shared paper)Ulf Ellwanger (1 shared paper)Martín C. Mihm (1 shared paper)Alona Muzikansky (1 shared paper)Soheil Sam Dadras (1 shared paper)David G. Jackson (1 shared paper)Lawrence F. Brown (1 shared paper)
- Journals
- Marine Biotechnology (4 papers)Cancer Research (2 papers)Journal of Virology (2 papers)Virology (2 papers)Advances in Therapy (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Thomas A. Paul
32 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Oncology 538
- Molecular Biology 1.0k
- Virology 52
- Hematology 118
- Cancer Research 141
Countries citing papers authored by Thomas A. Paul
This map shows the geographic impact of Thomas A. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Paul more than expected).
Fields of papers citing papers by Thomas A. Paul
This network shows the impact of papers produced by Thomas A. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Paul. The network helps show where Thomas A. Paul may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas A. Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 422 | |
| 2 | 2015 | 222 | |
| 3 | 2017 | 216 | |
| 4 | 2001 | 96 | |
| 5 | 2020 | 71 | |
| 6 | 2010 | 65 | |
| 7 | 2020 | 50 | |
| 8 | 2023 | 48 | |
| 9 | 2013 | 46 | |
| 10 | 2024 | 45 | |
| 11 | 2001 | 43 | |
| 12 | 2010 | 43 | |
| 13 | 2012 | 41 | |
| 14 | 2006 | 39 | |
| 15 | 2020 | 29 | |
| 16 | 2021 | 24 | |
| 17 | 2012 | 22 | |
| 18 | 2020 | 19 | |
| 19 | 2010 | 14 | |
| 20 | 2001 | 9 |
About Thomas A. Paul
Thomas A. Paul is a scholar working on Molecular Biology, Oncology, Genetics, Animal Science and Zoology and Hematology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (3 papers), Aquaculture disease management and microbiota (3 papers), Animal Virus Infections Studies (3 papers), Ubiquitin and proteasome pathways (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Oncology (538 citations), Molecular Biology (1.0k citations), Virology (52 citations), Hematology (118 citations) and Cancer Research (141 citations). Thomas A. Paul has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Claus Garbe, Michael J. Detmar, Ulf Ellwanger, Martín C. Mihm, Alona Muzikansky, Soheil Sam Dadras, David G. Jackson, Lawrence F. Brown, Shikhar Sharma and Linda Wolff. Their work appears in journals such as Marine Biotechnology, Cancer Research, Journal of Virology, Virology and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.